P2X and P2Y receptors—role in the pathophysiology of the nervous system
- PMID: 25530618
- PMCID: PMC4284787
- DOI: 10.3390/ijms151223672
P2X and P2Y receptors—role in the pathophysiology of the nervous system
Abstract
Purinergic signalling plays a crucial role in proper functioning of the nervous system. Mechanisms depending on extracellular nucleotides and their P2 receptors also underlie a number of nervous system dysfunctions. This review aims to present the role of purinergic signalling, with particular focus devoted to role of P2 family receptors, in epilepsy, depression, neuropathic pain, nervous system neoplasms, such as glioma and neuroblastoma, neurodegenerative diseases like Parkinson's disease, Alzheimer's disease and multiple sclerosis. The above-mentioned conditions are associated with changes in expression of extracellular ectonucleotidases, P2X and P2Y receptors in neurons and glial cells, as well as releasing considerable amounts of nucleotides from activated or damaged nervous tissue cells into the extracellular space, which contributes to disturbance in purinergic signalling. The numerous studies indicate a potential possibility of using synthetic agonists/antagonists of P2 receptors in treatment of selected nervous system diseases. This is of particular significance, since numerous available agents reveal a low effectiveness and often produce side effects.
Similar articles
-
Purinergic signaling and the functioning of the nervous system cells.Cell Mol Biol Lett. 2015 Dec;20(5):867-918. doi: 10.1515/cmble-2015-0050. Cell Mol Biol Lett. 2015. PMID: 26618572 Review.
-
Medicinal chemistry of adenosine, P2Y and P2X receptors.Neuropharmacology. 2016 May;104:31-49. doi: 10.1016/j.neuropharm.2015.12.001. Epub 2015 Dec 12. Neuropharmacology. 2016. PMID: 26686393 Free PMC article. Review.
-
The therapeutic potential of purinergic signalling.Biochem Pharmacol. 2018 May;151:157-165. doi: 10.1016/j.bcp.2017.07.016. Epub 2017 Jul 21. Biochem Pharmacol. 2018. PMID: 28735873 Review.
-
Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages.Immunobiology. 2011 Jan-Feb;216(1-2):1-11. doi: 10.1016/j.imbio.2010.03.010. Epub 2010 Apr 9. Immunobiology. 2011. PMID: 20471713
-
The P2Y/P2X divide: How it began.Biochem Pharmacol. 2021 May;187:114408. doi: 10.1016/j.bcp.2021.114408. Epub 2021 Jan 11. Biochem Pharmacol. 2021. PMID: 33444568 Review.
Cited by
-
P2X7 receptor-pannexin 1 interaction mediates extracellular alpha-synuclein-induced ATP release in neuroblastoma SH-SY5Y cells.Purinergic Signal. 2017 Sep;13(3):347-361. doi: 10.1007/s11302-017-9567-2. Epub 2017 May 17. Purinergic Signal. 2017. PMID: 28516276 Free PMC article.
-
Smooth muscle cells, interstitial cells and neurons in the gallbladder (GB): Functional syncytium of electrical rhythmicity and GB motility (Review).Int J Mol Med. 2023 Apr;51(4):33. doi: 10.3892/ijmm.2023.5236. Epub 2023 Mar 17. Int J Mol Med. 2023. PMID: 36928163 Free PMC article. Review.
-
Purinergic Signaling and Related Biomarkers in Depression.Brain Sci. 2020 Mar 12;10(3):160. doi: 10.3390/brainsci10030160. Brain Sci. 2020. PMID: 32178222 Free PMC article.
-
The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy.Front Pharmacol. 2018 Mar 7;9:193. doi: 10.3389/fphar.2018.00193. eCollection 2018. Front Pharmacol. 2018. PMID: 29563872 Free PMC article. Review.
-
Adenine Nucleotides Control Proliferation In Vivo of Rat Retinal Progenitors by P2Y1 Receptor.Mol Neurobiol. 2017 Sep;54(7):5142-5155. doi: 10.1007/s12035-016-0059-0. Epub 2016 Aug 24. Mol Neurobiol. 2017. PMID: 27558237
References
-
- North R.A. Molecular physiology of P2X receptors. Physiol. Rev. 2002;82:1013–1067. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical